Medikit Co Stock

Medikit Co Equity

The The Equity of Medikit Co (7749.T) as of Aug 26, 2026 is 45.16 B JPY. In the previous year, The Equity was 44.13 B JPY — a change of 2.33% (higher).

Equity

45.16 BJPY

YoY

2.33%

Last updated:

In 2026, Medikit Co's equity was 45.16 B JPY, a 2.33% increase from the 44.13 B JPY equity in the previous year.

The Medikit Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
38.15 B JPY
Jan 1, 2019
40.05 B JPY
Jan 1, 2020
42.17 B JPY
Jan 1, 2021
43.64 B JPY
Jan 1, 2022
45.77 B JPY
Jan 1, 2023
47.29 B JPY
Jan 1, 2024
44.13 B JPY
Jan 1, 2025
45.16 B JPY
The Medikit Co Equity history
YEAREquityYoY
45.16 BJPY+2.33%
44.13 BJPY-6.69%
47.29 BJPY+3.32%
45.77 BJPY+4.89%
43.64 BJPY+3.48%
42.17 BJPY+5.29%
40.05 BJPY+4.98%
38.15 BJPY+4.93%
36.36 BJPY+5.41%
34.49 BJPY+4.63%
32.96 BJPY-2.49%
33.81 BJPY—
Access this data via the Eulerpool API
Get Free API Key

Medikit Co Stock analysis

What does Medikit Co do? The history of the company Medikit Co Ltd dates back to the 1970s, when the company was founded as a small family business in Japan. Over time, Medikit grew into a multinational company with offices in Asia, Europe, and North America. Medikit's business model is focused on developing, manufacturing, and selling innovative medical devices and consumables. The company specializes in three areas: Medical Instruments, Medical Consumables, and Medical Technology. In the field of Medical Instruments, Medikit offers a wide range of products for use in diagnosis and therapy. These include endoscopes for examining hollow organs such as the stomach and intestines, as well as flexible endoscopes for examining bronchi and lungs. In addition, the range includes ultrasound devices for diagnosing heart, blood vessel, and musculoskeletal disorders, as well as surgical instruments for use in minimally invasive surgery. In the field of Medical Consumables, Medikit offers bandages, injection and infusion sets, catheters and urinary drainage systems, as well as blood collection systems. Products for home care, such as ostomy care and incontinence supplies, are also part of the portfolio. In the field of Medical Technology, Medikit offers technologies for telemedicine and hospital routine. These include systems for wireless transmission of vital parameters such as blood pressure and heart rate, as well as data storage and processing systems for medical examination data. Medikit is constantly striving to improve its products and offer customers the best products. This has resulted in Medikit having one of the best research and development departments in medical technology. Research is conducted, among other things, on better diagnostic procedures and new surgical methods. Another important aspect of Medikit's business model is to work closely with medical facilities and professionals to better understand the needs of customers and offer them customized solutions. This is also reflected in the numerous trainings and workshops that Medikit offers for medical professionals. Overall, Medikit Co Ltd has established itself as a reliable and innovative provider in medical technology. By combining top-notch products with excellent service, the company demonstrates that it stands by its customers in every situation. Medikit Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Medikit Co's Equity

Medikit Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Medikit Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Medikit Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Medikit Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Medikit Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Medikit Co stock

The Equity of Medikit Co is 45.16 B JPY in 2026.

The Equity of Medikit Co changed from 44.13 B JPY to 45.16 B JPY, representing a 2.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Medikit Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Medikit Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Medikit Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Medikit Co